论文部分内容阅读
目的:观察中药微调3号方预防晚期肺癌患者口服美施康定片所致便秘发生的临床疗效。方法:口服美施康定片同时,观察组口服中药微调3号方,对照组口服乳果糖。结果:观察组未发生便秘17例,发生便秘4例;对照组未发生便秘10例,发生便秘11例。观察组预防便秘发生优于对照组。结论:中药微调3号方预防晚期肺癌患者口服美施康定片所致便秘发生,疗效肯定。
OBJECTIVE: To observe the clinical efficacy of Chinese medicine fine-tuning No.3 prescription in preventing the occurrence of constipation caused by oral administration of schokedine tablets in patients with advanced lung cancer. Methods: Simultaneous oral administration of schestacine tablets, oral observation of oral Chinese medicine fine-tuning No. 3, the control group oral lactulose. Results: In the observation group, there were no constipation in 17 cases and constipation in 4 cases. In the control group, there were no constipation in 10 cases and 11 constipation cases. The observation group had better prevention of constipation than the control group. Conclusion: Chinese medicine fine-tuning No.3 prescription prevents the occurrence of constipation caused by oral administration of schokedine tablets in patients with advanced lung cancer, and the curative effect is positive.